# Clinical Trial Protocol: XYZ-2026-Alpha

## Objective
To evaluate the efficacy of Drug Alpha in patients with moderate hypertension.

## Inclusion Criteria
1. Patients aged 18-65.
2. Diagnosed with Stage 1 hypertension.

## Exclusion Criteria
1. Pregnant or lactating women.
2. Known allergy to Drug Alpha.

## Informed Consent
Participants will sign a consent form before the study begins. The process follows general guidelines.

## Safety Monitoring
Severe events will be reported within a reasonable timeframe.

## Statistical Methods
The study will enroll 100 participants.
